Molecular Capabilities CBS Labs offers comprehensive molecular diagnostics capabilities including PCR, QPCR, RT-PCR, Next Generation Sequencing and DNA microarrays, indicating strong potential for collaborations in clinical diagnostics, research partnerships, and expanded testing services.

US Caribbean Reach With clients across the US and the Caribbean servicing private practices, clinics, institutions, universities, and biotech/pharma entities, there is opportunity to expand contract research and forensic/toxicology testing collaborations in diverse markets.

Mid sized Authority As a small to mid-sized lab with 11-50 employees and revenue in the one to ten million range, CBS Labs may be highly agile for pilot projects, white-label services, and customized testing programs with faster onboarding.

Tech Stack Fit Reliance on widely adopted platforms such as WordPress, MySQL and Gravity Forms suggests ease of marketing, client portal integrations, and potential for scalable customer onboarding and data management solutions.

Growth Potential Revenue visibility and broad service lines across molecular diagnostics align with opportunities to upsell high-margin services like NGS-based screening, toxicology reporting, and pathology analytics to hospital systems and research institutions.